DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Desvenlafaxine Succinate is a drug marketed by Actavis Labs Fl, Alembic Pharms Ltd, Hikma Pharms, Intellipharmaceutics, Lupin Ltd, Mylan, Rubicon, Yichang Humanwell, and Zydus Pharms. and is included in ten NDAs.
The generic ingredient in DESVENLAFAXINE SUCCINATE is desvenlafaxine succinate. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the desvenlafaxine succinate profile page.
A generic version of DESVENLAFAXINE SUCCINATE was approved as desvenlafaxine succinate by ALEMBIC PHARMS LTD on June 29th, 2015.
Summary for DESVENLAFAXINE SUCCINATE
|Finished Product Suppliers / Packagers:||16|
|Raw Ingredient (Bulk) Api Vendors:||33|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for DESVENLAFAXINE SUCCINATE|
|What excipients (inactive ingredients) are in DESVENLAFAXINE SUCCINATE?||DESVENLAFAXINE SUCCINATE excipients list|
|DailyMed Link:||DESVENLAFAXINE SUCCINATE at DailyMed|
Recent Clinical Trials for DESVENLAFAXINE SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
|CSPC ZhongQi Pharmaceutical Technology Co., Ltd.||Phase 3|
|Korea Cancer Center Hospital||Phase 4|
|Seoul National University Hospital||Phase 4|